Selected Reading
AAP Committee on Infectious Diseases. Antiviral therapy and prophylaxis for influenza in children. Pediatrics 2007 Apr;119(4):852-60
AAP Committee on Infectious Diseases. Prevention of influenza: recommendations for influenza immunization of children, 2006-2007. Pediatrics 2007 Apr;119(4):846-51
AAP Committee on Infectious Diseases. Prevention of influenza: recommendations for influenza immunization of children, 2007-2008. (Policy Statement) Pediatrics 2008 Apr;121(4):e1016-31
AAP Committee on Infectious Diseases. Prevention of influenza: recommendations for influenza immunization of children, 2008-2009. (Policy Statement) Pediatrics 2008 (published online Oct 1)
Aballea s, De Juanes JR, Barbieri M, et al. The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain. Vaccine 2007 Sep 28;25(39-40):6900-10
Abed Y, Goyette N, Boivin G. Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations. Antimicrob Agents Chemother 2005 Feb;49(2):556-9
Ablah E, Konda K, Tinius A, et al. Influenza vaccine coverage and presenteeism in Sedgwick County, Kansas. Am J Infect Control 2008 Oct;36(8):588-91
Abramson JS, Neuzil KM, Tamblyn SE. Annual universal influenza vaccination: ready or not? Clin Infect Dis 2006 Jan 1;42(1):132-5
Alarcon JB, Hartley AW, Harvey NG, et al. Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines. Clin Vaccine Immunol 2007 Apr;14(4):375-81
Albright FS, Orlando P, Pavia AT, et al. Evidence for a heritable predisposition to death due to influenza. J Infect Dis 2008 Jan;197 (published online Dec 11, 2007)
Ali T, Scott N, Kallas W, et al. Detection of influenza antigen with rapid antibody-based tests after intranasal influenza vaccination (FluMist). Clin Infect Dis 2004 Mar 1;38(5):760-2
Alonso WJ, Viboud C, Simonsen L, et al. Seasonality of influenza in Brazil: a traveling wave from the Amazon to the subtropics. Am J Epidemiol 2007 (published online Mar 16)
Ambrose CS, Yi TT, Walker RE, et al. Duration of protection provided by live attenuated influenza vaccine in children. Pediatr Infect Dis J 2008 Aug;27(8):744-8
Amorij JP, Saluja V, Petersen AH, et al. Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice. Vaccine 2007 Dec 17;25(52):8707-17
Ansaldi F, Bacilieri S, Durando P, et al. Cross-protection by MF59(TM)-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses. Vaccine 2008 Mar 17;26(12):1525-9
Apisarnthanarak A, Puthavathana P, Kitphati R, et al. Outbreaks of influenza A among nonvaccinated healthcare workers: implications for resource-limited settings. Infect Control Hosp Epidemiol 2008;29 (published online Jul 14)
Apisarnthanarak A, Puthavathana P, Mundy LM. Risk factors and outcomes of influenza A (H3N2) pneumonia in an area where avian influenza (H5N1) is endemic. Infect Control Hosp Epidemiol 2007 Apr;28(4):479-82
Arkema JM, Paget WJ, Meijer A, et al. Seasonal influenza beginning in Europe: report from EISS. Eurosurveillance Weekly 2007 Jan 25;12(1):E070125.3
Arkema JMS, Meijer A, Meerhoff TJ, et al. Epidemiological and virological assessment of influenza activity in Europe, during the 2006-2007 winter. Eurosurveillance Aug 21;13(34):pi=18958
Arnoux S, Weinberger C, Gessner BD. Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip--an activated split virion influenza vaccine--supports wider vaccine use. Vaccine 2007 Nov 7;25(45):7720-31
Ashkenazi S, Vertruyen A, Aristegui J, et al. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Ped Infect Dis J 2006 Oct;15(10):870-9
Aspinall R, Del Giudice G, Effros RB, et al. Challenges for vaccination in the elderly. Immun Ageing 2007;4:9 (published online Dec 11)
Atmar RL, Keitel WA, Patel SM, et al. Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. Clin Infect Dis 2006 Nov 1;43(9):1135?42
Aucs P, Buchholz U, Haas W, et al. Influenza associated excess mortality in Germany, 1985-2001. Emerg Themes Epidemiol 2005 Jun 21;2:6
Auewarakul P, Kositanont U, Sornsathapornkul P, et al. Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine 2007 Jan 8;25(4):659-63
Babcock HM, Merz LR, Dubberke ER, et al. Case-control study of clinical features of influenza in hospitalized patients. Infect Control Hosp Epidemiol 2008 Oct;19(10):921-6
Baldo V, Baldovin T, Floreani A, et al. MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications. Vaccine 2007 May 16;25(20):3955-61
Balicer RD, Huerta M, Levy Y, et al. Influenza outbreak control in confined settings. Emerg Infect Dis 2005 Apr;11(4):579-83
Bardenheier B, Shefer A, McKibben L, et al. Characteristics of long-term care facility residents associated with receipt of influenza and pneumococcal vaccinations. Infect Control Hosp Epidemiol 2004 Dec;25(11):946-54
Baz M, Abed Y, McDonald J, et al. Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child. Clin Infect Dis 2006 Dec 15;43(12):1555-61
Beckett CG, Kosasih H, Ma'roef C, et al. Influenza surveillance in Indonesia: 1999-2003. Clin Infect Dis 2004 Aug 15;39(4):443-9
Beigel J, Bray M. Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res 2008 Apr;78(1):91-102
Belongia EA, Coleman LA, Donahue JG. Effectiveness of influenza vaccination. (Letter) N Engl J Med 2007 Dec 27;357(26):2728-31
Belsche RB. Translational research on vaccines: influenza as an example. Clin Pharmacol Ther 2007 Dec;82(6):745-9
Belshe RB, Edwards KM, Vesikari T, et al. Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med 2007 Feb 15;256(7):685-96
Belshe RB, Gruber WC, Mendelman PM, et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr 2000 Feb;136(2):168-75
Belshe RB, Newman FK, Cannon J, et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 2004 Nov 25;351(22):2286-94
Belshe RB, Newman FK, Wilkins K, et al. Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults. Vaccine 2007 Sep 17;25(37-38):6755-63
Belshe RB, Nichol KL, Black SB, et al. Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years. Clin Infect Dis 2004 Oct 1;39(7):920-7
Benito-Fernandez J, Vazquez-Ronco M, Morteruel-Aizkuren E, et al. Impact of rapid viral testing for influenza A and B viruses on management of febrile infants without signs of focal infection. Ped Infect Dis J 2006 Dec;25(12):1153-7
Bergen R, Black S, Shinefield H, et al. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr Infect Dis J 2004 Feb;23(2):138-44
Besselaar TG, Naidoo D, Buys A, et al. Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa. (Letter) Emerg Infect Dis 2008 Nov (published online Sep 25)
Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005 Dec 15;353(24):2559-67
Bishburg E, Shah M, Mathis AS. Influenza vaccination among medical residents in a teaching hospital. Infect Control Hosp Epidemiol 2008 Jan;29(1):89-91
Blackburne BP, Hay AJ, Goldstein RA. Changing selective pressure during antigenic changes in human influenza H3. PLoS Pathog 2008 May 2;4(5):e1000058
Blank PR, Schwenkglenks M, Szucs TD. Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health 2008 Aug 1;8:272
Bodor M, Montalvo E. Vaccination-related shoulder dysfunction. Vaccine 2007 Jan 8;25(4):585-7
Borlaug G, Newman A, Pfister J, et al. Factors that influenced rates of influenza vaccination among employees of Wisconsin acute care hospitals and nursing homes during the 2005-2006 influenza season. Infect Control Hosp Epidemiol 2007 Dec;28(12):1398-1400
Bose ME, Littrell JC, Patzer AD, et al. The influenza primer design resource: a new tool for translating influenza sequence data into effective diagnostics. Influenza Other Resp Viruses 2008 Jan;2(1):23-31
Bouvier NM, Lowen AC, Palese P. Oseltamivir-resistant influenza A viruses transmit efficiently among guinea pigs by direct contact but not by aerosol. J Virol 2008 Oct;82(20):10052-8
Bragstad K, Nielsen LP, Fomsgaard A. The evolution of human influenza A viruses from 1999 to 2006 - a complete genome study. Virol J 2008 Mar 7;5(1):40
Brankston G, Gitterman L, Hirji A, et al. Transmission of influenza A in human beings. Lancet Infect Dis 2007, published online Feb 19
Brett AS, Zuger A. The run on Tamiflu: should physicians prescribe on demand? (Perspective) N Engl J Med 2005 Dec 22;353(24):2636-7
Brewer NT, Hallman WK. Subjective and objective risk as predictors of influenza vaccination during the vaccine shortage of 2004-2005. Clin Infect Dis 2006 Dec 1;43(11):1379-86
Bright RA, Carter DM, Daniluk S, et al. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 2007 May 10;25(19):3781-8
Bright RA, Medina M, Xu X, et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 2005 Oct 1;366(9492):1175-81
Bright RA, Shay DK, Shu B, et al. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 2006 (published online Feb 2)
Bright RA, Shay DK, Shu B, et al. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 2006 Feb 22;295(8):891-4
Brooks WA, Terebuh P, Bridges C, et al. Influenza A and B infection in children in urban slum, Bangladesh. (Letter) Emerg Infect Dis 2007 Oct;13(10):1507-8
Brown AS, Begg MD, Gravenstein S, et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 2004;61(8):774-80
Brownstein JS, Kleinman KP, Mandl KD. Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system. Am J Epidemiol 2005 Oct 1;162(7):686-93
Brownstein JS, Wolfe CJ, Mandl KD. Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States. PLoS Med 2006 Oct;3(10)
Bryant KA, Stover B, Cain L, et al. Improving influenza immunization rates among healthcare workers caring for high-risk pediatric patients. Infect Control Hosp Epidemiol 2004 Dec;25(11):912-7
Bucher SJ, Brickner PW, Vincent RL. Influenzalike illness among homeless persons. (Letter) Emerg Infect Dis 2006 Jul;12(7)
Bui HH, Peters B, Assarsson E, et al. Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci 2007 Jan 2;104(1):246-51
Bulimo WD, Garner JL, Schnabel DC, et al. Genetic analysis of H3N2 influenza A viruses isolated in 2006-2007 in Nairobi, Kenya. Influenza Other Resp Viruses 2008 (published online Jun 2)
Burbacher TM, Shen DD, Liberato N, et al. Comparison of blood and brain mercury levels in infant monkeys exposed to methylmercury or vaccines containing thimerosal. Environ Health Perspect 2005 (published online Apr 21)
Cabello J, Das K, Trick WE, et al. House staff attitudes about influenza vaccination after participation in a clinical trial to improve vaccination of hospital patients. Infect Control Hosp Epidemiol 2008 Feb (published online Dec 28)
Carpenter LR, Lott J, Lawson BM, et al. Mass distribution of free, intranasally administered influenza vaccine in a public school system. Pediatrics 2007 (published online Jun 25)
Carrat F, Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007 Sep 28;25(39-40):6852-62
Carrat F, Vergu E, Ferguson NM, et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol 2008 Apr 1;167(7):775-85
CDC. 2005-06 U.S. influenza season summary. Jul 21, 2006
CDC. Assessment of the effectiveness of the 2003-04 influenza vaccine among children and adults: Colorado, 2003. MMWR Aug 13;53(31):707-10
CDC. Brief report: Influenza vaccination coverage among children aged 6-23 months--six immunization information system sentinel sites, United States, 2005-06 influenza season. MMWR 2006 Dec 15;55(49):1329-30
CDC. CDC guidelines for large-scale influenza vaccination clinic planning. May 23, 2007
CDC. CDC guidelines for large-scale influenza vaccination clinic planning: guidelines for the tiered use of inactivated influenza vaccine. May 23, 2007
CDC. CDC recommends against the use of amantadine and rimantadine for the treatment or prophylaxis of influenza in the United States during the 2005-2006 influenza season. CDC Health Alert. Jan 14, 2006
CDC. Childhood influenza vaccination coverage--United States, 2004-05 influenza season. MMWR 2006 Oct 6;55(39):1062-5
CDC. Childhood influenza vaccination coverage: United States, 2003-04 influenza season MMWR 2006 Feb 3;55(04):100-3
CDC. Childhood influenza-vaccination coverage: United States, 2002-03 influenza season. MMWR 2004 Sep 24;53(37):863-6
CDC. Composition of the 2005-06 influenza vaccine. Published Apr 18, 2005; updated May 13, 2005
CDC. Destruction of influenza A (H2N2) proficiency testing samples; interim guidance for biosafety level 3-enhanced biocontainment for work with human influenza A (H2N2) viruses. May 3, 2005
CDC. Estimated influenza vaccination coverage among adults and children--United States, September 1, 2004-January 31, 2005. MMWR 2005 April 1;54(12):304-7
CDC. Estimates of influenza vaccination target population sizes in 2006 and recent vaccine uptake levels. Jul 17, 2006
CDC. Experiences with influenza-like illness and attitudes regarding influenza prevention: United States, 2003-04 influenza season. MMWR 2004 Dec 17;53(49):1156-8
CDC. Flu vaccine effectiveness: questions and answers for health professionals. Published online Jan 11, 2007
CDC. High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents: United States 2005-06 influenza season. MMWR 2006 Jan 17;55(Dispatch):1-2
CDC. Increased antiviral medication sales before the 2005-06 influenza season: New York City. MMWR 2006 Mar 17;55(10):277-9
CDC. Infection control measures for preventing and controlling influenza transmission in long-term care facilities. Revised Dec 23, 2005
CDC. Influenza activity--United States and worldwide, 2007-08 season. MMWR 2008 Jun 27;57(26):692-97
CDC. Influenza activity--United States and worldwide, May 18-September 19, 2008. MMWR 2008 Sep 26;57(38):1046-9
CDC. Influenza activity: United States and worldwide, 2005-06 season, and composition of the 2006-07 influenza vaccine. MMWR 2006 Jun 16;55(23)648-53
CDC. Influenza activity: United States and worldwide, May 21 - September 9, 2006. MMWR 2006 Sep 22;55(37):1021-3
CDC. Influenza activity: United States and worldwide, May 22 - Sep 3, 2005, and 2005-06 season vaccination recommendations. MMWR 2005 Sep 16;54(36):899-902
CDC. Influenza activity: United States, October 1 - December 9, 2006. MMWR 2006 Dec 22;55(50):1359-62
CDC. Influenza activity: United States, September 30-December 1, 2007. MMWR 2007 Dec 14;56(49):1287-91
CDC. Influenza and pneumococcal vaccination coverage among persons aged >/=65 Years--United States, 2004-2005. MMWR 2006 Oct 6;55(39):1065-8
CDC. Influenza and pneumonococcal vaccination coverage among persons aged >/=65 years with diabetes or asthma: United States, 2003. MMWR 2004 Nov 5;53(43):1007-12
CDC. Influenza antiviral medications: 2005-06 interim chemoprophylaxis and treatment guidelines. Oct 21, 2005
CDC. Influenza vaccination and self-reported reasons for not receiving influenza vaccination among Medicare beneficiaries aged >/=65 years: United States, 1991-2002. MMWR 2004 Nov 5;53(43):1012-5
CDC. Influenza vaccination coverage among children aged 6-23 months--United States, 2005-06 influenza season. MMWR 2007 Sep 21;56(37):959-63
CDC. Influenza vaccination coverage among children aged 6-23 Months--United States, 2006-07 influenza season. MMWR 2008 Sep 26;57(38):1039-43
CDC. Influenza vaccination coverage among children aged 6-59 Months--eight immunization information system sentinel sites, United States, 2007-08 influenza season. MMWR 2008 Sep 26;57(38):1043-6
CDC. Influenza vaccination coverage among children aged 6-59 months--six immunization information system sentinel sites, United States, 2006-07 influenza season. MMWR 2007 Sep 21;56(37):963-5
CDC. Influenza vaccination coverage among children with asthma--United States, 2004-05 influenza season. MMWR 2007 Mar 9;56(9):193-6
CDC. Influenza vaccination coverage among persons aged 50-64 years enrolled in commercial managed health-care plans. MMWR 2005 Sep 23;54(37):921-3
CDC. Influenza vaccination coverage among persons with asthma--United States, 2005-06 influenza season. MMWR 2008 Jun 20;57(24):653-7
CDC. Influenza vaccination in pregnancy: practices among obstetrician-gynecologists: United States, 2003-04 influenza season. MMWR 2005 Oct 21;54(41):1050-2
CDC. Influenza vaccination levels among persons aged >/=65 years and among persons aged 18-64 years with high-risk conditions: United States, 2003. MMWR 2005 Oct 21;54(41):1045-9
CDC. Influenza vaccine prebooking and distribution strategies for the 2005-06 influenza season. MMWR 2005 April 1;54(12):307-8
CDC. Influenza vaccine supply and recommendations for prioritization during the 2005-06 influenza season. MMWR 2005 Sep 2;54(34):850
CDC. Influenza-associated pediatric mortality and Staphylococcus aureus co-infection. (CDC Health Advisory) Jan 30, 2008
CDC. Influenza-associated pediatric mortality and the increase of Staphylococcus aureus co-infection. (CDC Health Advisory) May 9, 2007
CDC. Influenza-testing and antiviral-agent prescribing practices--Connecticut, Minnesota, New Mexico, and New York, 2006-07 influenza season. MMWR 2008 Jan 25;57(3):61-5
CDC. Interim CDC-NIH recommendation for raising the biosafety level for laboratory work involving noncontemporary human influenza (H2N2) viruses. Excerpted from draft: Biosafety in microbiological and biomedical laboratories. Ed 5. May 3, 2005
CDC. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season. MMWR 2008 Apr 18;57(15):393-8
CDC. Interventions to increase influenza vaccination of health-care workers. MMWR 2005 Mar 4;54(8)
CDC. Notice to readers: Expansion of use of live attenuated influenza vaccine (FluMist) to children aged 2-4 years and other FluMist changes for the 2007-08 influenza season. MMWR Nov 23;56(46):1217-9
CDC. Notice to readers: National Influenza Vaccination Week--November 26-December 2, 2007. MMWR Nov 23;56(46):1216-7
CDC. Preventing the spread of influenza (the flu) in child care settings: guidance for administrators, care providers, and other staff. Posted Oct 2, 2007
CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR 2007 Jun 29;56(Early Release):1-54
CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR 2008 Jul 17;57(Early Release):1-60
CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2006 Jun 28;55(Early release):1-41
CDC. Q&A: Seasonal influenza vaccine supply for the U.S. 2007-08 influenza season. Oct 12, 2007
CDC. Q&A: Thimerosal in seasonal influenza vaccine. Oct 12, 2007
CDC. Questions & answers: vaccine effectiveness (How well does the influenza or 'flu' vaccine work?). Published online Jan 11, 2007
CDC. Rapid assessment of influenza vaccination coverage among HMO members: northern California influenza seasons, 2001-02 through 2004-05. MMWR 2005 Jul 15;54(27):676-8
CDC. Severe morbidity and mortality associated with influenza in children and young adults: Michigan, 2003. MMWR 2003:52(35):837-40
CDC. State-specific influenza vaccination coverage among adults aged >/= 18 years--United States, 2003-04 and 2005-06 influenza seasons. MMWR 2007 Sep 21;56(37):953-9
CDC. State-specific influenza vaccination coverage among adults--United States, 2006-07 influenza season. MMWR 2008 Sep 26;57(38):1033-9
CDC. Surveillance for laboratory-confirmed, influenza-associated hospitalizations: Colorado, 2004-05 influenza season. MMWR 2005 Jun 3;54(21):535-7
CDC. Tiered use of inactivated influenza vaccine in the event of a vaccine shortage. MMWR 2005 Aug 5;54(30):749-50
CDC. Update on the influenza vaccine supply and distribution. Nov 10, 2005
CDC. Update: influenza activity--United States and worldwide, 2006-07 season, and composition of the 2007-08 influenza vaccine. MMWR 2007 Aug 10;56(31):789-94
CDC. Update: influenza activity--United States and worldwide, May 20-September 15, 2007. MMWR 2007 Sep 28;56(3):1001-4
CDC. Update: influenza activity--United States, October 1, 2006-February 3, 2007. MMWR 2007 Feb 16;56(6):118-21
CDC. Update: influenza activity--United States, September 30, 2007-April 5, 2008, and composition of the 2008-09 influenza vaccine. MMWR 2008 Apr 18;57(15):404-9
CDC. Update: influenza activity--United States, September 30, 2007-February 9, 2008. MMWR 2009 Feb 15;57(early release):1-5
CDC. Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2003 Sep 26:52(RR13):1
CDC. Vaccination coverage among callers to a state influenza hotline: Connecticut, 2004-2005 influenza season. MMWR 2005 Mar 4;54(8)
CDC/NIH. Statement on Simonsen et al article "Impact of influenza vaccination on seasonal mortality in the US elderly population" below. Feb 2005
Chen G-W, Yang C-C, Tsao K-C, et al. Influenza A virus PB1-F2 gene in recent Taiwanese isolates. Emerg Infect Dis 2004 Apr;10 (4):630-8
Chen GW, Shih SR, Hsiao MR, et al. Multiple genotypes of influenza B viruses cocirculated in Taiwan in 2004 and 2005. J Clin Microbiol 2007 May;45(5):1515-22
Chen J, Zhang F, Fang F, et al. Vaccination with hemagglutinin or neuraminidase DNA protects BALB/c mice against influenza virus infection in presence of maternal antibody. BMC Infect Dis 2007;7:118 (published online Oct 16)
Chi RC, Neuzil KM, Lipsky BA, et al. Where high-risk adults receive influenza vaccine during a shortage. Arch Intern Med 2007 Nov 26;167(21):2366-8
Chiu SS, Peiris JSM, Chan KH, et al. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children. Pediatrics 2007 Jun;119(6):1076-82
Cho BH, Kolasa MS, Messonnier ML. Influenza vaccination coverage rate among high-risk children during the 2002-2003 influenza season. Am J Infect Control 2008 Oct;36(8):582-7
Chou CH, Liou WP, Hu KI, et al. Bell's palsy associated with influenza vaccination: two case reports. Vaccine 2007 Apr 12;25(15):2839-41
Chow A, Ma S, Ling AE, et al. Influenza-associated deaths in tropical Singapore. Emerg Infect Dis 2006 Jan;12(1)
Christenson B, Pauksen K, Sylvan SP. Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity. Virology J 2008 Apr 28;5:52
Christini AB, Shutt KA, Byers KE. Influenza vaccination rates and motivators among healthcare worker groups. Infect Control Hosp Epidemiol 2007 Feb;28(2):171-7
Coady MH, Galea S, Blaney S, et al. Project VIVA: a multilevel community-based intervention to increase influenza vaccination rates among hard-to-reach populations in New York City. Am J Public Health 2008 Jul;98(7):1314-21
Coffin SE, Zaoutis TE, Wheeler Rosenquist AB, et al. Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics 2007 Apr(4);119:740-8
Cohen NJ, Morita JY, Plate DK, et al. Control of an outbreak due to an adamantane-resistant strain of influenza A (H3N2) in a chronic care facility. Infection 2008 (published online Sep 14)
Cohen S, Alper CM, Doyle WJ, et al. Positive emotional style predicts resistance to illness after experimental exposure to rhinovirus or influenza A virus. Psychosom Med 2006 (published online Nov 13)
Coleman MS, Fontanesi J, Meltzer MK, et al. Estimating medical practice expenses from administering adult influenza vaccinations. Vaccine 2005 Jan 4;23(7):915-23
Colina R, Costa-Mattioli M, Dowling RJO, et al. Translational control of the innate immune response through IRF-7. Nature 2008 Mar 20;452(7185):323-8 (published online Feb 13)
Cooper DL, Smith GE, Regan M, et al. Tracking the spatial diffusion of influenza and norovirus using telehealth data: a spatio-temporal analysis of syndromic data. BMC Med 2008 Jun 26;6:16
Couch RB, Winokur P, Brady R, et al. Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine 2007 Nov 1;25(44):7656-63
Cowling BJ, Lau EHY, Lam CLH, et al. Effects of school closures, 2008 winter influenza season, Hong Kong. Emerg Infect Dis 2008 Oct;14(10) (published online Sep 11)
Cox NJ, Bridges CB. Inactivated and live attenuated influenza vaccines in young children--how do they compare? (Editorial) N Engl J Med 2007 Feb 15;256(7):729-31
Crawford LM. FDA's ongoing efforts to ensure the safety, effectiveness, and availability of influenza and other vaccines. Testimony before Senate Special Committee on Aging. Nov 16, 2004
Crepey P, Barthelemy M. Detecting robust patterns in the spread of epidemics: a case study of influenza in the United States and France. Am J Epidemiol 2007 (published online Oct 15)
D'Heilly SJ, Nichol K. Work-site-based influenza vaccination in healthcare and non-healthcare settings. Infect Control Hosp Epidemiol 2004 Dec;25(11):941-5
Das K, Ma LC, Xiao R, et al. Structural basis for suppression of a host antiviral response by influenza A virus. Proc Natl Acad Sci 2008 (published online Aug 25)
Daum LT, Shaw M, Klimov AI, et al. Influenza A (H3N2) outbreak, Nepal. Emerg Infect Dis 2005 Aug;11(8)
Davila JC, Payne DC, Zhang Y, et al. Quality assessment of nonanthrax vaccination data in the Defense Medical Surveillance System, 1998-2004. Vaccine 2008 Mar 17;26(12):1577-84
Dawson ED, Moore CL, Smagala JA, et al. MChip: a tool for influenza surveillance. Anal Chem Nov 15;78(22):7610-5
de Bruijn I, Meyer I, Gerez L, et al. Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly. Vaccine 2007 Dec 21;26(21):119-27
Denis J, Acosta-Ramirez E, Zhao Y, et al. Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV). Vaccine 2008 Jun 25;26(27-28):3395-403
Desbiens NA. A 5-year experience with influenza prevention and containment in a program of all-inclusive care for elderly adults. Am J Infect Control 2005 May;33(4):238-42
DesRoches CM, Blendon RJ, Benson JM. Americans' responses to the 2004 influenza vaccine shortage. Health Affairs 2005 May 24(3):822-31
Deyde VM, Xu X, Bright RA, et al. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis 2007 Jul 15;196(2):249-57
Dimmock NJ, Rainsford EW, Scott PD, et al. Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral. J Virol 2008 Sep;82(17):8570-78
Dodds L, McNeill SA, Fell DB, et al. Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women. CMAJ 2007 Feb 13;176(4):463-8
Doherty PC, Kelso A. Toward a broadly protective influenza vaccine. (Commentary) J Clin Invest 2008 (published online Sep 18)
Dolin R. Influenza: interpandemic as well as pandemic disease. (Perspective) N Engl J Med 2005 Dec 15;353(24):2535-7
Donato AA, Motz LM, Wilson G, et al. Efficacy of multiple influenza vaccine delivery systems in a single facility. Infect Control Hosp Epidemiol 2007 Feb;28(2):219-21
Doratotaj S, Macknin ML, Worley S. A novel approach to improve influenza vaccination rates among health care professionals: a prospective randomized controlled trial. Am J Infect Control 2008 May;36(4):301-303
Doshi P. Trends in recorded influenza mortality: United States, 1900-2004. Am J Public Health 2008 (published online Apr 1)
Durando P, Fenoglio D, Boschini A, et al. Safety and immunogenicity of two influenza subunit vaccines, with or without MF59 adjuvant, administered to HIV-1 seropositive and seronegative adults. Clin Vaccine Immunol 2007 (published online Nov 14)
Dushoff J, Plotkin JB, Viboud C, et al. Vaccinating to protect a vulnerable subpopulation. PLoS Med 2007 May;4(5):e174
Duwe S, Schweiger B. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1. J Virol Method 2008 (published online Aug 22)
Dwyer DE, Smith DW, Catton MG, et al. Laboratory diagnosis of human seasonal and pandemic influenza virus infection. Med J Aust 2006 Nov 20;185(10 suppl):S48-53
Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 2005 Nov;5(11):718-25
ECDC (European Centre for Disease Prevention and Control). Oseltamivir resistance in seasonal influenza viruses in Europe. Feb 13, 2008
ECDC (European Center for Disease Prevention and Control). Resistance to oseltamivir (Tamiflu) found in some European influenza virus samples. ECDC News 2008 Feb 7
ECDC Influenza Project Team. Oseltamivir resistance in human seasonal influenza viruses (A/H1N1) in EU and EFTA countries: an update. Eurosurveill 2008 Feb 7;13(6)
Eichelberger M, Golding H, Hess M, et al. FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007. Vaccine 2008 Aug 12;26(34):4299-303
El Sahly HM, Keitel WA. Clinical data on Fluarix: an inactivated split seasonal influenza vaccine. Expert Rev Vaccines 2008 Aug;7(6):713-9
Eliasson DG, Bakkouri KE, Schon K, et al. CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine. Vaccine 2008 Feb 26;26(9);1243-52
Esposito S, Gasparini C, Martelli A, et al. Safe administration of an inactivated virosomal adjuvanted influenza vaccine in asthmatic children with egg allergy. Vaccine 2008 Aug 26;26(36):4664-8
Esposito S, Tremolati E, Bellasio M, et al. Attitudes and knowledge regarding influenza vaccination among hospital health workers caring for women and children. Vaccine 2007 Jul 20;25(29):5283-9
Eurosurveillance Editorial Team. Influenza activity in the Southern Hemisphere: a preliminary look at the winter 2007 season. Eurosurveillance Weekly 2007 Aug 23;12(8):E070823.4
Eurosurveillance Editorial team. New WHO influenza vaccine recommendations for 2007-2008 season, northern hemisphere. Eurosurveillance Weekly 2007 Apr 5;12(4):E070405.4
Fabian P, McDevitt JJ, DeHaan WH, et al. Influenza virus in human exhaled breath: an observational study. PLoS ONE 2008 Jul 16;3(7):e2691
Falsey AR, Murata Y, Walsh EE. Impact of rapid diagnosis on management of adults hospitalized with influenza. Arch Intern Med 2007;167(4) (published online Jan 22)
Fauci AS. Seasonal and pandemic influenza preparedness: science and countermeasures. J Infect Dis 2006 Nov 1;194(suppl 2):S73-6
FDA. FDA clears first test designed to detect and identify 12 respiratory viruses from single sample. Jan 3, 2008, news release
FDA. Guidance for industry: clinical data needed to support the licensure of seasonal inactivated influenza vaccines. May 31, 2007
Fedson DS. Vaccination for pandemic influenza and severe acute respiratory syndrome: common issues and concerns. (Editorial Commentary) Clin Infect Dis 2003 Jun 15;36(12):1562-3
Ferko B, Kittel C, Romanova J, et al. Live attenuated influenza virus expressing human interleukin-2 reveals increased immunogenic potential in young and aged hosts. J Virol 2006 Dec;80(23):11621-7
Finelli L, Fiore A, Dhara R, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 2008 Oct;122(4):805-11
Finkelman BS, Viboud C, Koelle K, et al. Global patterns in seasonal activity of influenza A/H3N2, A/H1N1, and B from 1997 to 2005: viral coexistence and latitudinal gradients. PLoS ONE Dec 12;2(12):e1296
Fleming DM, Crovari P, Wahn U, et al. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Ped Infect Dis J 2006 Oct;15(10):860-9
France EK, Smith-Ray R, McClure D, et al. Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits. Arch Pediatr Adolesc Med 2006 Dec 160(12):1277-83
Fraser C, Riley S, Anderson RM, et al. Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci 2004 Apr 20;101(16):6146-51
Frech SA, Kenney RT, Spyr CA, et al. Improved immune responses to influenza vaccination in the elderly using an immunostimulant patch. Vaccine 2005 Jan 4;23(7):946-50
Frisbie B, Tang YW, Griffin M, et al. Surveillance of childhood influenza virus infection: what is the best diagnostic method to use for archival samples? J Clin Microbiol 2004 Mar;42(3):1181-4
Fujisawa H. Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice. J Virol 2008 Mar;82(6):2772-83
Fukuda K, Kieny MP. Different approaches to influenza vaccination. N Engl J Med 2006 Dec 14;355(24):2586-7
Gaglia MA Jr, Cook RL, Kraemer KL, et al. Patient knowledge and attitudes about antiviral medication and vaccination for influenza in an internal medicine clinic. Clin Infect Dis 2007 Nov 1;45(9):1182-8
Gallagher KM, Juhasz M, Harris NS, et al. Predictors of influenza vaccination in HIV-infected patients in the United States, 1990-2002. J Infect Dis 2007 Aug 1;196(3):339-46
Galvani AP, Reluga TC, Chapman GB. Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proc Natl Acad Sci 2007 (published online Mar 16)
GAO (Government Accountability Office). Federal challenges in responding to influenza outbreaks. Testimony of Janet Heinrich before Special Committee on Aging, US Senate. GAO-04-1100T. Sep 28, 2004
GAO (Government Accountability Office). Flu vaccine: recent supply shortages underscore ongoing challenges. Congressional testimony by Janet Heinrich. GAO-05-177T. Nov 18, 2004
GAO (US Government Accountability Office). Influenza vaccine: issues related to production, distribution, and public health messages. GAO-08-27. Released Nov 16, 2007 (but dated Oct 31)
Gatrad AR, Shafi S, Memish ZA, et al. Hajj and the risk of influenza (Editorial). BMJ 2006 Dec 9;333(7580):1182-3
Gaydos JC, Top FH Jr, Hodder RA, et al. Swine influenza A outbreak, Fort Dix, New Jersey, 1976. Emerg Infect Dis 2006 Jan;12(1)
Gazmararian JA, Coleman M, Prill M, et al. Influenza vaccination of health care workers: policies and practices of hospitals in a community setting. Am J Infect Control 2007 Sep;25(7):441-7
Ge Q, Filip L, Bai A, et al. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc Natl Acad Sci 2004 Jun 8;101(23):8676-81
Gerberding J. Letter to healthcare providers on National Influenza Vaccination Week. Nov 21, 2006
Gerberding JL. Influenza and influenza vaccine safety and supply. Statement before House Committee on Appropriations Subcommittee on Labor, Health and Human Services & Education. Oct 5, 2004
Gerhard W, Mozdzanowska K, Zharikova D. Prospects for universal influenza virus vaccine. Emerg Infect Dis 2006 Apr; 12(4)
Ghedin E, Sengamalay NA, Shumway M, et al. Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature 2005 Oct 20;437(7062):1162-6
Ghendon YZ, Markuskin SG, Akopova II, et al. Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine. Vaccine 2005 Sep 7;23(38):4678-84
Ghosh TS, Vogt RL. Active influenza surveillance at the local level: a model for local health agencies. Am J Public Health 2008 Feb;98(2):213-5
Gill TK, Taylor AW, Watson M. Trends in influenza immunisation amongst an elderly Australian community. Vaccine 2007 Jul 20;25(29):5428-32
Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996;18(1):64-76
Glezen WP. Modifying clinical practices to manage influenza in children effectively. Pediatr Infect Dis J 2008 Aug;27(8):738-43
Gocnik M, Fislova F, Mucha V, et al. Antibodies induced by the HA2 glycopolypeptide of influenza virus haemagglutinin improve recovery from influenza A virus infection. J Gen Virol 2008 Apr;89(4):958-67
Goldstein AO, Kincade JE, Gamble G, et al. Policies and practices for improving influenza immunization rates among healthcare workers. Infect Control Hosp Epidemiol 2004 Dec;25(11):908-11.
Goldstein AO, Kincade JE, Resnick JE, et al. Policies to increase influenza and pneumococcal immunizations in chronically ill and institutionalized settings. Am J Infect Control 2005 Oct;33(8):463-8
Goodman MJ, Nordin JD, Harper P, et al. The safety of trivalent influenza vaccine among healthy children 6 to 24 months of age. Pediatrics 2006 May;117(5):e821-6
Green MD, Nettey H, Wirtz RA. Determination of oseltamivir quality by colorimetric and liquid chromatographic methods. Emerg Infect Dis 2008 Apr (published online Mar 5)
Gregersen JP. A quantitative risk assessment model of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine. Vaccine 2008 Jun 19;26(26):3332-40
Gregersen JP. A risk-assessment model to rate the occurence and relevance of adventitious agents in the production of influenza vaccines. Vaccine 2008 Jun 19;26(26):3297-304
Grijalva CG, Craig AS, Dupont WD, et al. Estimating influenza hospitalizations among children. Emerg Infect Dis 2006 Jan;12(1)
Grijalva CG, Poehling KA, Edwards KM, et al. Accuracy and interpretation of rapid influenza tests in children. Pediatrics 2007 Jan;119(1):e6-11
Grimm D, Staeheli P, Hufbauer M, et al. Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene. Proc Natl Acad Sci 2007 (published online Apr 10)
Guarner J, Paddock CD, Shieh WJ, et al. Histopathologic and immunohistochemical features of fatal influenza virus infection in children during the 2003-2004 season. Clin Infect Dis 2006 Jul 15;43(2):132-40
Guebre-Xabier M, Hammond SA, Ellingsworth LR, et al. Immunostimulant patch enhances immune responses to influenza virus vaccine in aged mice. J Virol 2004 Jul 15;78(14):1610-8
Gundlapalli AV, Rubin MA, Samore MH, et al. Influenza, winter Olympiad, 2002. Emerg Infect Dis 2005 Jan;12(1)
Guthrie T, Hobbs CG, Davenport V, et al. Parenteral influenza vaccination influences mucosal and systemic T cell-mediated immunity in healthy adults. J Infect Dis 2004 Dec 1;190(11):1927-35
Hak E, Buskens E, van Essen GA, et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med 2005 Feb 14;165(3):274-80
Hak E, Wei F, Nordin J, et al. Development and validation of a clinical prediction rule for hospitalization due to pneumonia or influenza or death during influenza epidemics among community-dwelling elderly persons. J Infect Dis 2004 Feb 1;189(3):450-8
Halasa NB, Gerber MA, Chen Q, et al. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants. J Infect Dis 2008 (published online Apr 7)
Haldar J, An D, Alvarez de Cienfuegos L, et al. Polymeric coatings that inactivate both influenza virus and pathogenic bacteria. Proc Natl Acad Sci 2006 Nov 21;103(47):17667-71
Hale BG, Randall RE, Ortin J, et al. The multifunctional NS1 protein of influenza A viruses. J Gen Virol 2008 Oct;89(10):2359-76
Halloran ME, Hayden FG, Yang Y, et al. Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. Am J Epidemiol 2007 Jan 15;165(2):212-21
Halloran ME, Longini IM. Community studies for vaccinating schoolchildren against influenza. Science 2006 Feb 3;311(5761):615-6
Halloran ME, Piedra PA, Longini IM Jr, et al. Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004. Vaccine 2007 May 16;25(20):4038-45
Hambidge SJ, Glanz JM, France EK, et al. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. JAMA 2006 Oct 25;296(10):1990-7
Handel A, Longini IM Jr, Antia R. Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread. PLoS Comp Biol 2007 Dec 7;3(12):e240
Hao L, Sakurai A, Watanabe T, et al. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 2008 Aug 14;454(7206):890-3
Harris A, Cardone G, Winkler DC, et al. Influenza virus pleiomorphy characterized by cryoelectron tomography. Proc Natl Acad Sci 2006 Dec 12;103(50):19123-7
Hatakeyama S, Sugaya N, Ito M, et al. Emergence of influenza B viruses with reduced sensitivity to neuraminidase. JAMA 2007 Apr 4;297(13):1435-42
Hay AJ, Gregory V, Douglas AR, et al. The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci 2001 Dec 29;356(1416):1861-70
Hayden FG, Belshe R, Villanueva C, et al. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J Infect Dis 2004 Feb 1;189(3):440-9
Hayden FG, Pavia AT. Antiviral management of seasonal and pandemic influenza. J Infect Dis 2006 Nov 1;194(suppl 2):S119-26
Hayward AC, Harling R, Wetten S, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ 2006;333 (published online Dec 1)
Heikkinen T, Silvennoinen H, Peltola V, et al. Burden of influenza in children in the community. J Infect Dis 2004 Oct 15;190(8):1369-73
Herlocher ML, Truscon R, Elias S, et al. Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets. J Infect Dis 2004 Nov 1;190(9):1627-30
Heymann A, Chodick G, Reichman B, et al. Influence of school closure on the incidence of viral respiratory diseases among children and on health care utilization. Pediatr Infect Dis J 2004 Jul;23(7):675-7
Hibbert CL, Piedra PA, McLaurin KK, et al. Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres. Vaccine 2007 Nov 19;25(47):8010-20
Holland D, Booy R, De Looze F, et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis 2008 (published online Jul 24)
Holm MV, Blank PR, Szucs TD. Developments in influenza vaccination coverage in England, Scotland, and Wales covering five consecutive seasons from 2001 to 2006. Vaccine 2007 Nov 14;25(46):7931-8
Holm MV, Blank PR, Szucs TD. Trends in influenza vaccination coverage rates in Germany over five seasons from 2001 to 2006. BMC Infect Dis 2007;7:144 (published online Dec 10)
Holmes EC, Ghedin E, Miller N, et al. Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol 2005 Sep;3(9)
Holodniy M, Penzak SR, Straight TM, et al. Pharmacokinetics and tolerability of oseltamivir combined with probenecid. Antimicrob Agents Chemother 2008 Sep;52(9):3013-21
Hota S, McGeer A. Antivirals and the control of influenza outbreaks. Clin Infect Dis 2007 Nov 15;45(10):1362-8
Hotchkiss JR, Strike DG, Crooke PS. Pathogen transmission and clinic scheduling. Emerg Infect Dis 2005 Jan;12(1)
Hourfar MK, Themann A, Eickmann M, et al. Blood screening for influenza. Emerg Infect Dis 2007 Jul;13(7):1081-3
Hubby B, Talarico T, Maughan M, et al. Development and preclinical evaluation of an alphavirus replicon vaccine for influenza. Vaccine 2007 Nov 23;25(48):8180-9
Huber VC, McCullers JA. Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets. J Infect Dis 2006 Mar 1;193(5):677-84
Huleatt JW, Nakaar V, Desai P, et al. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine 2008 Jan 10;26(2):201-14
Hull HF, Frauendienst RS, Gundersen ML, et al. School-based influenza immunization. Vaccine 2008 Aug 12;26(34):4312-3
Humberd J, Guan Y, Webster RG. Comparison of the replication of influenza A viruses in Chinese ring-necked pheasants and Chukar partridges. J Virol 2006 Mar;80(5):2151-61
IDSA (Infectious Diseases Society of America). Pandemic and seasonal influenza principles for US action. Released Jan 25, 2007
Ilyinskii PO, Gambaryan AS, Merlin AB, et al. Inhibition of influenza M2-induced cell death alleviates its negative contribution to vaccination efficiency. PLoS ONE 2008 Jan 16;3(1):e1417
Ilyushina NA, Govorkova EA, Russell CJ, et al. Contribution of H7 haemagglutinin to amantadine resistance and infectivity of influenza virus. J Gen Virol 2007 Apr;88(4):1266-74
Influenza team, ECDPC. Influenza transmission: research needs for informing infection control policies and practice. Eurosurveillance Weekly 2007 May 10;12(5):E070510.1
IOM (Institute of Medicine). Immunization safety review: vaccines and autism. Washington, DC: National Academies Press, 2004
Ip M, Tang JW, Hui DSC, et al. Airflow and droplet spreading around oxygen masks: a simulation model for infection control research. Am J Infect Control 2007 Dec;35(10):684-9
Ison MG, Gubareva LV, Atmar RL, et al. Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J Infect Dis 2006 Mar 15;193(6):760-4
Ison MG, Mishin V, Braciale TJ, et al. Comparative activities of oseltamivir and A-322278 in immunocompetent and immnocompromised murine models of influenza virus infection. J Infect Dis 2006 Mar 15;193(6):765-72
Iwane MK, Singleton JA, Walton K, et al. Assessing influenza vaccine utilization in physician offices serving adult patients: experience during a season of vaccine delays and shortages. J Public Health Manag Pract 2007 May/Jun;13(3):307-13
Iyer SB, Gerber MA, Pomerantz WJ, et al. Effect of point-of-care influenza testing on management of febrile children. Acad Emerg Med 2006 Dec;13(12):1259-68
Izurieta HS, Haber P, Wise RP, et al. Adverse events reported following live, cold-adapted, intranasal influenza vaccine. JAMA 2005 Dec 7;294(21):2720-5
Jackson LA, Neuzil KM, Baggs J, et al. Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study. Pediatrics 2006 Nov;118(5):2032-7
Jackson ML, Nelson JC, Weiss NS, et al. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 2008 Aug 2;372(9636):398-405
Jafri HS, Ramilo O, Makari D, et al. Diagnostic virology practices for respiratory syncytial virus and influenza virus among children in the hospital setting: a national survey. Ped Infect Dis J 2007 Oct;26(10):956-8
Jayasekera JP, Moseman EA, Carrol MC. Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J Virol 2007 Apr;81(7):3487-94
Jefferson T, Demicheli V, Rivetti D, et al. Antivirals for influenza in healthy adults: systematic review. Lancet 2006 Jan 28;367(9507):303-13
Jefferson T, Foxlee R, Del Mar C, et al. Interventions for the interruption or reduction of the spread of respiratory viruses. Cochrane Database Syst Rev 2007 Oct 17;(4):CD006207
Jefferson T, Rivetti D, Rivetti A, et al. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005 Oct 1;366(9492):1165-74
Jefferson T, Smith S, Demicheli V, et al. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet 2005;365(Feb 26):773-80
Jefferson T. Influenza vaccination: policy versus evidence. (Analysis and comment) BMJ 2006 Oct 28;333(7574):912-5
Jhee SS, Yen M, Ereshefsky L, et al. Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid of healthy Japanese and Caucasian volunteers. Antimicrobial Agents Chemother 2008 Oct;52(10):3687-93
Jian JW, Chen GW, Lai CT, et al. Genetic and epidemiological analysis of influenza virus epidemics in Taiwan during 2003 to 2006. J Clin Microbiol 2008 Apr;46(4);1426-34
Jimenez-Garcia R, Carrasco-Garrido P, Hernandez-Barrera V, et al. Estimates of influenza vaccination target population sizes in Spain for the 2006-2007 season. Vaccine 2007 Apr 30;25(17):3249-53
Johansson BE, Brett IC. Changing perspective on immunization against influenza. Vaccine 2007 Apr 20;25(16):3062-5
Jones TF, Ingram LA, Craig AS, et al. Determinants of influenza vaccination, 2003-2004: shortages, fallacies and disparities. Clin Infect Dis 2004 Dec 15;39(12):1824-8
Jordan R, Olowokure B. Indirect community protection against influenza by vaccinating children: a review of two recent studies from Italy and the United States. Eurosurveillance Weekly 2004 Dec 16;8(51)
Juurlink DN, Stukel TA, Kwong J, et al. Guillain-Barre syndrome after influenza vaccination in adults: a population-based study. Arch Intern Med 2006 Nov 13;166(20):2217-21
Katz MA, Tharmaphornpilas P, Chantra S, et al. Who gets hospitalized for influenza pneumonia in Thailand? Implications for vaccine policy. Vaccine 2007 May 10;25(19):3827-33
Kawai N, Ikematsu H, Iwaki N, et al. A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons. Clin Infect Dis 2006 Aug 15;43(4):439-44
Kawai N, Ikematsu H, Iwaki N, et al. A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B. J Infect 2007 (published online Oct 16)
Kawai N, Ikematsu H, Iwaki N, et al. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan on the 2002-2003 influenza season. Clin Infect Dis 2005 May 1;40(9):1309-16
Kawai N, Ikematsu H, Iwaki N, et al. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir. J Infect 2007 Sep;55(3):267-72
Keitel WA, Atmar RL, Cate TR, et al. Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med 2006 May 22;166(10:1121-7
Keitel WA, Atmar RL, Nino D, et al. Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different variants. J Infect Dis 2008 (published online Aug 25)
Keleta L, Ibricevic A, Bovin NV, et al. Experimental evolution of human influenza H3 hemagglutinin in the mouse lung identifies adaptive regions in HA1 and HA2. J Virol 2008 (published online Oct 1)
Kenney RT, Frech SA, Muenz L, et al. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 2004 Nov 25;351(22):2295-2301
Keren R, Zaoutis TE, Bridges CB, et al. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA 2005 Nov 2;294(17):2182-7
Keren R, Zaoutis TE, Saddlemire S, et al. Direct medical cost of influenza-related hospitalizations in children. Pediatrics 2006 Nov;118(5):1321-7
Kilbourne ED. What are the prospects for a universal influenza vaccine? Nat Med 1999 Oct;5(10):1119-20
Kimura AC, Nguyen CN, Higa JI, et al. The effectiveness of vaccine day and educational interventions on influenza vaccine coverage among health care workers at long-term care facilities. Am J Pub Health 2007 Apr;97(4) (published online Feb 28)
King JC Jr, Stoddard JJ, Gaglani MJ, et al. Effectiveness of school-based influenza vaccination. N Engl J Med 2006 Dec 14;355(24):2523-32
Kiso M, Mitamura K, Sakai-Tagawa Y, et al. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 2004 Aug 28;364(9436):759-65
Kochs G, Garcia-Sastre A, Martinez-Sobrido L. Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 2007 Jul;81(13):7011-21
Koelle K, Cobey S, Grenfell B, et al. Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 2006 Dec 22;314(5807):1898-903
Koerner I, Kochs G, Kalinke U. et al. Protective role of beta interferon in host defense against influenza A virus. J Virol Feb;81(4):2025-30
Kornish LJ, Keeney RL. Repeated commit-or-defer decisions with a deadline: the influenza vaccine composition. Operations Res 2008 May-Jun;56(3):527-41
Krasnitz M, Levine AJ, Rabadan R. Anomalies in the influenza virus genome database: new biology or laboratory errors? J Virol 2008 Sep;82(17):8947-50
Kreijtz JH, Bodewes R, van Amerongen G, et al. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Vaccine 2007 Jan 8;25(4):612-20
Kroneman M, Paget WJ, Meuwissen LE, et al. An approach to monitoring influenza vaccination uptake across Europe. Eurosurveillance 2008 May 15;13(20):pii=18874
Kroneman MW, van Essen GA. Stagnating influenza vaccine coverage rates among high-risk groups in Poland and Sweden in 2003/4 and 2004/5. Eurosurveillance Monthly 2007 Apr;12(4)
Kryazhimskiy S, Dieckmann U, Levin SA, et al. On state-space reduction in multi-strain pathogen models, with an application to antigenic drift in influenza A. PLoS Comput Biol 2007 Aug;3(8):e159
Kuiken T, Taubenberger JK. Pathology of human influenza revisited. Vaccine 2008 Sep 12;26(suppl 4):D59-66
Kuntz JL, Holley S, Helms CM, et al. Use of a pandemic preparedness drill to increase rates of influenza vaccination among healthcare workers. Infect Control Hosp Epidemiol 2008 Feb;29(2):111-5
Kwong JC, Rosella LC, Johansen H. Trends in influenza vaccination in Canada, 1996/1997 to 2005. Health Rep 2007 Nov;18(4) (released Oct 2)
La Montagne JR, Fauci AS. Intradermal influenza vaccination--can less be more? (Editorial) N Engl J Med 2004 Nov 25;351(22):2230-2
Lackenby A, Hungnes O, Dudman SG, et al. Emergence of resistance to oseltamivir among influenza A (H1N1) viruses in Europe. Eurosurveillance Weekly 2008 Jan 31;13(5)
Langley JM. Release of the statement on influenza for the 2007-2008 season from the National Advisory Committee on Immunization. CMAJ 2007 Oct 23;177(9):1025-6
Lau EHY, Cowling BJ, Ho LM, et al. Optimizing use of multistream influenza sentinel surveillance data. Emerg Infect Dis 2008 Jul (published online Jun 6)
Lautenbach E, Tolomeo P, Mao X, et al. Duration of outpatient fecal colonization due to Escherichia coli isolates with decreased susceptibility to fluoroquinolones: longitudinal study of patients recently discharged from the hospital. Antimicrob Agents Chemother 2006 Nov;50(11):3939-43
LaVela SL, Smith B, Weaver FM, et al. Attitudes and practices regarding influenza vaccination among healthcare workers providing services to individuals with spinal cord injuries and disorders. Infect Control Hosp Epidemiol 2004 Dec;25(11):933-40
Layne SP. Human influenza surveillance: the demand to expand
Lee LHW, Ha DLA, Simmons C, et al. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 2008 (published online Sep 18)
Lee MS, Chen JSE. Predicting antigenic variants of influenza A/H3N2 viruses. Emerg Infect Dis 2004 Aug;10(8):1385-90
Lee MS, Chen MC, Liao YC, et al. Identifying potential immunodominant positions and predicting antigenic variants of influenza A/H3N2 viruses. Vaccine 2007 Nov 23;25(48):8133-9
Lee TH. Rationing influenza vaccine. N Engl J Med 2004 Dec 2;351(23):2365-6
Leekha S, Zitterkopf NL, Espy MJ, et al. Duration of influenza A virus shedding in hospitalized patients and implications for infection control. Infect Control Hosp Epidemiol 2007 Sep;28(9):1071-6
Lemay R, Mawudeku A, Shi Y, et al. Syndromic surveillance for influenzalike illness. Biosecur Bioterror 2008 Jun;6(2):161-70
Lemieux C, Brankston G, Gitterman L, et al. Questioning aerosol transmission of influenza. (Letter) Emerg Infect Dis 2007 Jan;13(1) (published online Dec 8)
Lenschow DJ, Lai C, Frias-Staheli N, et al. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci 2007 (published online Jan 16)
Lewis EN, Griffin MR, Szilagyi PG, et al. Childhood influenza: number needed to vaccinate to prevent 1 hospitalization or outpatient visit. Pediatrics 2007 Sep;120(3):467-72
Li D, Saito R, Le MTQ, et al. Genetic analysis of influenza A/H3N2 and A/H1N1 viruses circulating in Vietnam from 2001 to 2006. J Clin Microbiol 2008 Feb;46(2):399-405
Li W, Liu Y, Mukhtar MM, et al. Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PLos ONE 2008 Apr 16;3(4):e1985
Lin JH, Chiu SC, Le CH, et al. Genetic and antigenic analysis of epidemic influenza viruses isolated during 2006-2007 season in Taiwan. J Med Virol 2008 Feb;80(2):316-22
Lin JH, Tseng CP, Chen YJ, et al. Rapid differentiation of influenza A virus subtypes and genetic screening for virus variants by high-resolution melting analysis. J Clin Microbiol 2008 Mar;46(3):1090-7
Lindley MC, Groom AV, Wortley PM, et al. Status of influenza and pneumococcal vaccination among older American Indians and Alaska natives. Am J Public Health 2008 (published online Apr 1)
Lipatov AS, Govorkova EA, Webby RJ, et al. Influenza: emergency and control. J Virol 2004 Sep 1;78(17):8951-9
Lofgren E, Fefferman NH, Naumov YN, et al. Influenza seasonality: underlying causes and modeling theories. J Virol 2007 Jun;81(11):5429-36
Long BR, Michaelsson J, Loo CP, et al. Elevated frequency of gamma interferon-producing NK cells in healthy adults vaccinated against influenza virus. Clin Vaccine Immunol 2008 Jan;15(1):120-30
Longini IM, Halloran ME. Strategy for distribution of influenza vaccine to high-risk groups and children. (Commentary) Am J Epidemiol 2005 Feb 15;161(4):303-6
Look JL, Butler B, Al-Khalili M, et al. The adjuvant patch: a universal dose sparing approach for pandemic and conventional vaccines. BioPharm Int 2007 Aug (supp) (published online Aug 2)
Lopalco PL, Giesecke. Panel of international experts concludes on influenza and pneumococcal vaccination in Europe. Eurosurveillance Weekly 2007 Jan 18;12(1):E07118.1
Low D. Reducing antibiotic use in influenza: challenges and rewards. Clin Microbiol Infect 2008 Apr;14(4):298-306
Lowen AC, Mubareka S, Steel J, et al. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog 2007 Oct 19;3(10):e151
Lowen AC, Steel J, Mubareka S, et al. High temperature (30 deg C) blocks aerosol but not contact transmission of influenza virus. J Virol 2008 Jun;82(11):5650-2
Lu B, Zhou H, Ye D, et al. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase acctivities. J Virol 2005 Jun 1;79(11):6763-71
Lu P, Bridges CB, Euler GL, et al. Influenza vaccination of recommended adult populations, US, 1989-2005. Vaccine 2008 Mar 25;26(14):1786-93
Luce BR, Nichol KL, Belshe RB, et al. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States. Vaccine 2008 June 2;26(33):2841-8
Lugo NR. Wi
